Biren Technology Returns to the Market a Third Time in Ten Months With a $515 Million Share Sale

Shanghai Biren Technology, one of the Chinese GPU designers grouped under the "Four Little Dragons" label alongside Moore Threads and MetaX, said on October 8 that it will place 130 million new H shares at HK$31.08 apiece, targeting gross proceeds of roughly HK$4.04 billion, or about $515 million. It is the company's third major capital raise since it listed in Hong Kong on January 2, and the second time this year it has gone back to public investors to fund a chip roadmap that is still burning cash.

The price leaves little room for sentiment. HK$31.08 is a discount of close to 9.76 percent to Biren's last close and 13.73 percent to its five-day average, and the new shares represent roughly 9.54 percent of the existing H-share count and 5 percent of total shares outstanding. No shareholder vote is required. According to SCMP, the stock dropped about 12 percent when the placement surfaced, although it remains up roughly 70 percent year to date and about 76 percent above its IPO price.

The cadence is the story. Biren priced its IPO on January 2 at HK$19.60, selling 284.8 million H shares for about HK$5.58 billion, roughly $717 million, and closed its first trading day 76 percent above the offer. In July it sold another 153 million shares at HK$46.20 for about HK$7.07 billion, roughly $892.5 million, under a 90-day lockup that expired at the start of October. Investors have now had three chances to decline. They have not taken one.

Biren says about 70 percent of the net proceeds will go to supply-chain procurement, production ramp-up and commercialization of its next-generation GPU line, the part of the business where Chinese chipmakers are most exposed because they still depend on foreign foundry and packaging capacity. Another 20 percent is earmarked for research and the software ecosystem around its chips, and the remaining 10 percent for working capital.

The financial backdrop is the usual one for this cohort. Biren's revenue expanded nearly twenty-fold in the first half of 2026, yet the company still lost RMB 377 million and continues to spend heavily on research relative to sales. The placement is therefore as much about securing scarce manufacturing capacity ahead of demand as it is about balance-sheet repair.

The wider context is Washington's export-control regime. The US imposed a license requirement on Nvidia's H20 exports to China in April 2025, after earlier rounds had already restricted Chinese designers' access to leading-edge foundries. Peers Moore Threads and MetaX raised a combined roughly $1.65 billion in Shanghai STAR Market IPOs in late 2025, and Moore Threads reported first-half 2026 revenue of RMB 1.736 billion, up 147.42 percent year over year and already ahead of its entire 2025 total.

What the sequence shows is that Hong Kong has become the default funding venue for Chinese AI chip companies whose US-linked financing options have narrowed. Each placement is framed, fairly or not, as a bet on domestic substitution, and each one has been absorbed. Whether Biren can eventually match Nvidia's performance at volume remains an open question. Whether it can keep raising while it tries no longer is.